Prevalence of Chronic liver disease in Cholangiocarcinoma: a Meta-Analysis.

Cholangiocarcinoma Chronic liver disease Epidemiology Prevalence

Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
24 Oct 2024
Historique:
received: 02 07 2024
revised: 15 09 2024
accepted: 17 09 2024
medline: 27 10 2024
pubmed: 27 10 2024
entrez: 26 10 2024
Statut: aheadofprint

Résumé

Chronic liver disease is a known risk factor for cholangiocarcinoma (CCA), but the proportion of people with CCA who have concurrent chronic liver disease is unclear. We aimed to evaluate the prevalence of chronic liver diseases in people with cholangiocarcinoma. In this single-arm meta-analysis, we searched MEDLINE and EMBASE from inception to 10 August 2024 for articles in English containing data for cholangiocarcinoma with and without chronic liver diseases. Data were pooled to obtain the prevalence of different chronic liver diseases, with further stratification by geographical location and tumor location. In total, 118068 individuals diagnosed with cholangiocarcinoma were included, of whom 16771 had chronic liver diseases. A pooled analysis of 109 studies determined that the prevalence of chronic liver disease was 25.23% (95% CI: 20.82% - 30.23%; I Around one in four people with cholangiocarcinoma have chronic liver diseases, and one in ten have cirrhosis.

Identifiants

DOI: 10.1016/j.cgh.2024.09.028 PMID: 39461458
pubmed: 39461458
pii: S1542-3565(24)00971-6
doi: 10.1016/j.cgh.2024.09.028
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Ethan Kai Jun Tham (EKJ)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Ryan Yanzhe Lim (RY)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Benjamin Koh (B)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Darren Jun Hao Tan (DJH)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Cheng Han Ng (CH)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.

Michelle Law (M)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Elina Cho (E)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Nicole Shu Ying Tang (NSY)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Claire Shiying Tan (CS)

Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore.

Benedix Kuan Loo Sim (BKL)

Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore.

En Ying Tan (EY)

Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore.

Wen Hui Lim (WH)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Mei Chin Lim (MC)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Diagnostic Imaging, National University Health System, Singapore.

Toru Nakamura (T)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan; Liver Cancer Research Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.

Pojsakorn Danpanichkul (P)

Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.

Sakkarin Chirapongsathorn (S)

Division of Gastroenterology and Hepatology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.

Karn Wijarnpreecha (K)

Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York, USA.

Hirokazu Takahashi (H)

Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga, Japan.

Asahiro Morishita (A)

Department of Gastroenterology and Neurology, Kagawa University, Kita-gun, Kagawa 761-0793, Japan.

Ming-Hua Zheng (MH)

MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Key Laboratory of Diagnosis and Treatment for the Development of Chronic liver disease in Zhejiang Province, Wenzhou, Zhejiang, China.

Alfred Kow (A)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Division of Hepatobiliary & Pancreatic Surgery, Department of Surgery, National University Hospital; National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore.

Mark Muthiah (M)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore; National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore.

Jia Hao Law (JH)

Division of Hepatobiliary & Pancreatic Surgery, Department of Surgery, National University Hospital. Electronic address: jia_hao_law@nuhs.edu.sg.

Daniel Q Huang (DQ)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore; National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore. Electronic address: daniel_huang@nus.edu.sg.

Classifications MeSH